Reconsider Beta-Blockers for Some Patients Post-MI

June 2024

Recent evidence will reignite debate about the role of beta-blockers post-MI...in patients withOUT heart failure.

Many of us were taught to give a beta-blocker to all post-MI patients as part of the usual “cocktail”...to reduce recurrent CV events.

But this is based on evidence from the 1980s...before routine use of stents, high-intensity statins, dual antiplatelet therapy, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote